A carregar...
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
Posaconazole (PCZ), approved for prophylaxis against invasive fungal disease in high-risk patients, is commercially available orally as a suspension formulation (PCZ-susp) and as a delayed-release tablet (PCZ-tab). We evaluated the serum steady-state concentrations (C(ss)) of PCZ stratified by the a...
Na minha lista:
Publicado no: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Microbiology
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4505228/ https://ncbi.nlm.nih.gov/pubmed/25987632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00581-15 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|